• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

概述并比较当代血管外科学会、美国心脏协会/美国心脏病学会和欧洲血管外科学会关于间歇性跛行患者管理的指南。

Overview and comparison of contemporary Society for Vascular Surgery, American Heart Association/American College of Cardiology, and European Society for Vascular Surgery guidelines for the management of patients with intermittent claudication.

机构信息

Department of Surgery, The Johns Hopkins Hospital, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Halsted 668, Baltimore, MD 21287.

Department of Surgery, The Johns Hopkins Hospital, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Halsted 668, Baltimore, MD 21287.

出版信息

Semin Vasc Surg. 2024 Jun;37(2):188-209. doi: 10.1053/j.semvascsurg.2024.04.006. Epub 2024 Apr 28.

DOI:10.1053/j.semvascsurg.2024.04.006
PMID:39151998
Abstract

Intermittent claudication (IC) is a phenotype of peripheral artery disease that is characterized by pain in the lower extremity muscles during activity that is relieved by rest. Medical management, risk factor control, smoking cessation, and exercise therapy have historically been the mainstays of treatment for IC, but advances in endovascular technology have led to increasing use of peripheral vascular interventions in this patient population. There are meaningful differences in published society guidelines and appropriate use criteria relevant to the management of IC, especially regarding indications for peripheral vascular interventions. The current review aims to highlight similarities and differences between major society recommendations for the management of IC, and to discuss practice trends, disparities, and evidence gaps in the use of peripheral vascular interventions for IC in the context of existing guidelines.

摘要

间歇性跛行(IC)是外周动脉疾病的一种表型,其特征是活动时下肢肌肉疼痛,休息后缓解。医学管理、危险因素控制、戒烟和运动疗法一直是 IC 治疗的主要方法,但血管内技术的进步导致在外周血管疾病患者人群中越来越多地使用血管介入治疗。在与 IC 管理相关的已发表的学会指南和适当使用标准方面存在显著差异,尤其是在外周血管介入治疗的适应证方面。本综述旨在强调主要学会建议在管理 IC 方面的相似性和差异性,并讨论在现有指南的背景下,外周血管介入治疗 IC 的实践趋势、差异和证据缺口。

相似文献

1
Overview and comparison of contemporary Society for Vascular Surgery, American Heart Association/American College of Cardiology, and European Society for Vascular Surgery guidelines for the management of patients with intermittent claudication.概述并比较当代血管外科学会、美国心脏协会/美国心脏病学会和欧洲血管外科学会关于间歇性跛行患者管理的指南。
Semin Vasc Surg. 2024 Jun;37(2):188-209. doi: 10.1053/j.semvascsurg.2024.04.006. Epub 2024 Apr 28.
2
Evaluating the management of intermittent claudication before and after publication of the Society of Vascular Surgery's Appropriate Use Criteria.评估血管外科学会合理使用标准发布前后间歇性跛行的管理情况。
J Vasc Surg. 2025 Aug;82(2):526-533.e3. doi: 10.1016/j.jvs.2024.12.133. Epub 2025 Jan 27.
3
A systematic review supporting the Society for Vascular Surgery guideline update on the management of intermittent claudication.一项支持血管外科学会间歇性跛行管理指南更新的系统评价。
J Vasc Surg. 2025 Aug;82(2):688-697. doi: 10.1016/j.jvs.2024.12.135. Epub 2025 Apr 30.
4
Society for Vascular Surgery Clinical Practice Guideline on the management of intermittent claudication: Focused update.血管外科学会间歇性跛行管理临床实践指南:重点更新
J Vasc Surg. 2025 Aug;82(2):303-326.e11. doi: 10.1016/j.jvs.2025.04.041. Epub 2025 Apr 30.
5
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
6
Management of claudication in older adults and the role of exercise therapy.老年人间歇性跛行的管理及运动疗法的作用。
Semin Vasc Surg. 2025 Sep;38(3):271-280. doi: 10.1053/j.semvascsurg.2025.07.005. Epub 2025 Jul 16.
7
Endovascular revascularisation versus conservative management for intermittent claudication.间歇性跛行的血管内血运重建与保守治疗对比
Cochrane Database Syst Rev. 2018 Mar 8;3(3):CD010512. doi: 10.1002/14651858.CD010512.pub2.
8
Long-term patient-reported outcomes among patients undergoing revascularization vs medical therapy for intermittent claudication.间歇性跛行患者行血运重建术与药物治疗的长期患者报告结局比较。
J Vasc Surg. 2024 Aug;80(2):466-477.e4. doi: 10.1016/j.jvs.2024.03.455. Epub 2024 Apr 10.
9
Omega-3 fatty acids for intermittent claudication.ω-3 脂肪酸治疗间歇性跛行。
Cochrane Database Syst Rev. 2024 Oct 29;10(10):CD003833. doi: 10.1002/14651858.CD003833.pub5.
10
German guideline on the diagnosis and treatment of peripheral artery disease - a comprehensive update 2016.《德国外周动脉疾病诊断与治疗指南——2016年全面更新》
Vasa. 2017 Mar;46(2):79-86. doi: 10.1024/0301-1526/a000603. Epub 2017 Jan 27.

本文引用的文献

1
Editor's Choice -- European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Asymptomatic Lower Limb Peripheral Arterial Disease and Intermittent Claudication.编辑推荐——欧洲血管外科学会(ESVS)2024年无症状下肢外周动脉疾病和间歇性跛行管理临床实践指南
Eur J Vasc Endovasc Surg. 2024 Jan;67(1):9-96. doi: 10.1016/j.ejvs.2023.08.067. Epub 2023 Nov 10.
2
Racial Disparities in Treatment Indications and Outcomes for Limb Ischemia.肢体缺血的治疗指征和结果存在种族差异。
Ann Vasc Surg. 2023 Oct;96:89-97. doi: 10.1016/j.avsg.2023.04.022. Epub 2023 Apr 30.
3
Sex and Racial Disparities in Peripheral Artery Disease.
外周动脉疾病中的性别和种族差异。
Arterioscler Thromb Vasc Biol. 2023 Nov;43(11):2099-2114. doi: 10.1161/ATVBAHA.123.319399. Epub 2023 Sep 14.
4
Revascularization for claudication: Changing the natural history of a benign disease!再血管化治疗跛行:改变良性疾病的自然病程!
J Vasc Surg. 2024 Jan;79(1):159-166. doi: 10.1016/j.jvs.2023.07.066. Epub 2023 Aug 22.
5
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA).2023ESH 动脉高血压管理指南 欧洲高血压学会动脉高血压管理工作组:得到国际高血压学会 (ISH) 和欧洲肾脏协会 (ERA) 的认可。
J Hypertens. 2023 Dec 1;41(12):1874-2071. doi: 10.1097/HJH.0000000000003480. Epub 2023 Sep 26.
6
Health Disparities in Peripheral Artery Disease: A Scientific Statement From the American Heart Association.外周动脉疾病中的健康差异:美国心脏协会的科学声明。
Circulation. 2023 Jul 18;148(3):286-296. doi: 10.1161/CIR.0000000000001153. Epub 2023 Jun 15.
7
Early peripheral vascular interventions for claudication are associated with higher rates of late interventions and progression to chronic limb threatening ischemia.早期外周血管介入治疗跛行与晚期介入治疗和进展为慢性肢体威胁性缺血的发生率较高相关。
J Vasc Surg. 2023 Mar;77(3):836-847.e3. doi: 10.1016/j.jvs.2022.10.025. Epub 2022 Oct 28.
8
Reprint of: Early peripheral vascular interventions for claudication are associated with higher rates of late interventions and progression to chronic limb threatening ischemia.早期外周血管介入治疗跛行与晚期介入治疗和进展为慢性肢体威胁性缺血的发生率较高相关。
J Vasc Surg. 2023 Jun;77(6):1720-1731.e3. doi: 10.1016/j.jvs.2023.04.023.
9
Editor's Choice - European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on Antithrombotic Therapy for Vascular Diseases.编辑推荐——欧洲血管外科学会(ESVS)2023年血管疾病抗栓治疗临床实践指南
Eur J Vasc Endovasc Surg. 2023 May;65(5):627-689. doi: 10.1016/j.ejvs.2023.03.042. Epub 2023 Apr 3.
10
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2023.9. 血糖治疗的药物学方法:2023 年糖尿病的护理标准。
Diabetes Care. 2023 Jan 1;46(Suppl 1):S140-S157. doi: 10.2337/dc23-S009.